Aimed Bio Inc.

Overview

Aimed Bio Inc., founded in 2018 as a spin-off from Samsung Medical Center, is a biotechnology company specializing in antibody-drug conjugates (ADCs) and bispecific antibodies. The company integrates patient-derived data throughout its development process to enhance precision and clinical relevance in cancer therapies.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Aimed Bio Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.